Safety Assessment & Testing

RCC offers a comprehensive range of toxicology safety assessment services for global registration mandate as per national & international guidelines and standards following OECD Principles of GLP. Studies shall also be conducted on mutually agreed experimental/study design for exploratory or non-regulatory studies.

Studies are performed using recommended animal models by various application routes. In addition, new animal models and techniques are being developed, validated and included in our service portfolio in line with rapid advances in the area of regulatory science.

If any of your study requirements are not listed, please contact us.

General Toxicology Studies

Assessing the safety of your product affordably

  • Well-trained and experienced team of GLP Toxicology Specialists.
  • GLP study designs based on the most up-to-date guidelines.
  • Meet your timelines with on-time reporting.
  • Quality at an affordable price.

Our Capabilities

Core Regulatory Toxicology Services

Dermal Toxicity Testing

in vitro
in vivo

Ocular Toxicology Services

in vitro
in vivo

Inhalation Services

Nose-Only Exposure

Infusion Services

Neurotoxicity Studies

Genetic Toxicology Studies

RCC provides a complete range of assays to determine the potential genetic toxicity such as genetic damage, genetic change, mutagenic drift etc. induced by test item.

Assessing Risk

  • Well-trained and experienced team of scientists offering genetic toxicology services.
  • GLP study designs based on the most up-to-date guidelines.
  • Meet your timelines with on-time reporting.
  • Quality at an affordable price.

Regulatory Assays

Nonclinical Pathology Assessment Services

RCC has well experienced veterinary pathologists as an integral part of the study team. Our services include necropsy, histology, clinical pathology and histopathological services. RCC meet your timelines with an integrated quality approach to ensure faster turnaround time.

1. Wide range of Clinical Pathology Services

  • Hematology, Clinical Chemistry (including T3, T4 and TSH), Coagulation {Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT)} and Urinalysis
  • Microscopy including bone marrow analysis
  • Screening for bacterial and viral pathogens by ELISA method
  • Specialized services for assessing neurotoxicity

2. Necropsy and Histology

  • Routine and specialized tissue collection/trimming following RITA classification

3. Toxicologic Pathology

  • Non-GLP Lead Optimization Studies
  • GLP studies for Early Development
  • Histology (paraffin)
  • Morphometry
  • Ocular Pathology
  • Sperm staining and morphology
  • Follicular counting
  • Single-cell splenic sub-population (CD4, CD8, B Lymphocyte, NK cells)

4. Developmental and Reproductive Toxicology (DART) and Pathology

5. Integrated interpretation/risk assessment

6. Pathology Peer Review